(Food-Beverage-News.Com, December 18, 2020 ) The vitamin D market, in terms of value, is estimated to account for nearly USD 1.1 billion in 2020 and projected to grow at a CAGR of 7.0%, to reach nearly USD 1.6 billion by 2025. The vitamin D market has been growing in accordance with the rise in demand and consumption of feed around the world. The feed industry is witnessing an upward trend in the demand for enriched feed products, which supports the demand for nutritional additives such as vitamin D. Furthermore, developing economies such as China and India, where there is a growing focus on animal nutrition, different vitamins are expected to experience a strong rise in the demand from the feed industry.
The dry segment is estimated to account for a larger share in the vitamin D market in 2020.
By form, the dry segment is estimated to account for a larger share in the market in 2020. The dry form of vitamin D is preferred by manufacturers due to its greater stability, ease of handling and storage, and convenience of usage in a wide range of products. Most of the vitamin D sold are synthetic. Vitamins D2 and D3 are mainly available in colorless crystals; their solubility in vegetable oil is low. The vitamin D3 analog is more stable as compared to that of vitamin D2. Vitamin D3 is estimated to be the majorly consumed vitamin D analog in the world.
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period.
The deficiency of vitamin D is widespread in Asia Pacific, particularly in South and Southeast Asia. Rickets (a deformity due to “soft bones”) is very common in China and is a result of poor vitamin D consumption. Furthermore, the rise in income levels and significant consumer demand for nutritional & healthy products are expected to provide promising prospects for the growth and diversification of the region’s functional food & beverage products, in turn, leading to growth in the consumption of vitamin-infused products, and thereby driving the market growth.
China and India are two of the most favorable markets for vitamin D manufacturers for expansion, due to the rising demand for animal feed, fortified food products, and easy availability of raw materials. It has become a key destination for manufacturers of vitamin D supplements and pharmaceutical product companies such as the Alkem Laboratories (India), Cadila Pharmaceuticals (India), Abbott Laboratories (US), and Sanofi S.A (France).
Vitamin D plays an important role in maintaining healthy bones and the regulation of immune systems; it is also associated with the prevention of heart disease, cancer, diabetes, and multiple sclerosis. The body requires sufficient vitamin D from a healthy diet and exposure to the sun. The major role of vitamin D is maintaining normal levels of calcium and phosphorus in the blood. It helps the body to absorb calcium, which forms and maintains strong bones. It also protects the body against osteoporosis, osteomalacia, rickets, and cancer. Vitamin D is found in food products such as fish, eggs, fortified milk, and cod liver oil.
The key players in the vitamin D market include Zhejiang Garden Biochemical High-Tech Co.,Ltd (China), Koninklijke DSM N.V. (Netherlands), Zhejiang Xinhecheng Co., Ltd. (China), Taizhou Haisheng Pharmaceutical Co., Ltd. (China), Xiamen Jindawei Vitamin Co., Ltd. (China), Fermenta Biotech Ltd. (India), Zhejiang Medicine Co., Ltd.(China), BASF (Germany), and Dishman Group (India). The key market players, along with the other players, adopted various business strategies such as new product launches, expansions, and joint ventures & agreements, in the last few years, to meet the growing demand for vitamin D.